![](https://webarchive.library.unt.edu/eot2008/20081107070547im_/http://nsf.gov/images/x.gif)
NSF Congressional Highlight
Congress Holds Hearings on the Administration's FY 2007 Budget Request and Nanotechnology
![](https://webarchive.library.unt.edu/eot2008/20081107070547im_/http://nsf.gov/images/greenline.jpg)
February 17, 2006
This week, the House Committee on Science held a hearing on the Administration's research and development budget request for FY 2007, and the Senate Commerce, Science and Transportation Committee held a hearing on developments in nanotechnology.
On Feb. 15, 2006, National Science Foundation Director Arden L. Bement, Jr., provided testimony on the agency's $6.02 billion budget request. Unveiled the previous week, the Administration's request would increase NSF's budget by $439 million, or 7.9 percent, over FY 2006. The increase is part of the President's American Competitiveness Initiative, which includes a commitment to double NSF's budget over the next 10 years. At the hearing, House Science Committee Chairman Sherwood Boehlert (R-NY) noted the strong support in Congress for the proposed 10-year doubling plan for NSF. Bement focused his testimony on NSF priorities and defended the investment in education activities. Read the hearing summary and Dr. Bement's testimony.
Also on Feb. 15, 2006, the Senate Commerce, Science and Transportation Committee, chaired by Sen. Ted Stevens (R-AK), held a hearing on "Developments in Nanotechnology." NSF's Acting Assistant Director for Engineering Richard O. Buckius provided testimony on NSF's commitment to fundamental academic research in the area of nanoscale science and technology. He appeared as a panelist with Dr. Clayton Teague, the director of the National Nanotechnology Coordinating Office, and Dr. Jeffrey Schloss, the co-chair of the Nanomedicine Roadmap Initiative of the National Institutes of Health. Buckius highlighted NSF's support for interdisciplinary research teams and centers, and provided several examples of early pay-offs from academic research. Read Dr. Buckius' testimony. More information about the hearing, including an archive webcast, is available at the Committee's Web site.
See also:
|